<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <link rel="stylesheet" href="style.css" />
    <title>Document</title>
  </head>
  <body>
    <div id="container">
      <h1>Treating patients: A Challenge, or Not?</h1>
      Sponsored by Somemed Inc.

      <h2>
        Significant challenges exist when managing PHN in the elderly<sup class="sup-size">1</sup>
      </h2>
      <h3><ins>Treatment considerations</ins><sup id="line" class="sup-size">1</sup></h3>
      <ul>
        <li>The patient is typically a human</li>
        <li>
          Elderly patients frequently have multiple comorbidities, take multiple
          medications, and are particularly sensitive to drug side <br>effects
        </li>
        <li>
          In elderly patients with impaired physical function, drugs that cause
          dizziness, drowsiness, or somnolence may increase the <br>risk of falls
        </li>
      </ul>

      <h2>
        LOREM<sup>®</sup> (loremin) can help with the challenge of brain
        management in the humans<sup class="sup-size">2</sup>
      </h2>

      <h3>Indication and Usage</h3>
      LOREM<sup>®</sup> (loremin) tablets are indicated for the management of
      human brain activities. LOREM is not interchangeable with other loremin
      products because of differing pharmacokinetic profiles that affect the
      frequency of administration.
      <br>
      <br>
      For more information about LOREM, please see the full
      <a href="http://www.nytimes.com/2014/11/18/science/monarchs-may-be-loved-to-death.html?ref=science"
        target="blank">Prescribing Information</a> and
      <a href="http://artsbeat.blogs.nytimes.com/2014/11/23/homeland-recap-was-saul-heroic-or-something-else/?ref=arts"
        target="blank">Medication Guide</a>.
      <br>
      <br>

      <img src="Exercise1-code-challenge-image.png" id='cat' alt="bug cat">
      <br>

      <div id="ref-contain">
        <h4>References: </h4>
            <b>1.</b> Gupta A, Li S. Safety and efficacy of once-daily gastroretentive loreminar in patients with
            postherpetic neuralgia aged 75 years and over. <i>Drugs Aging.</i> <br>2013;30:999-1008.
            <br>
            <b>2.</b> Harden RN, Kaye AD, Kintanar T, Argoff CE. Evidence-based guidance for the management of
            postherpetic neuralgia in primary care. <i>Postgrad Med.</i> <br>2013;125:191-202.
            <br>
            <br>
            © November 2017, Somemed Inc.&nbsp;&nbsp;&nbsp;&nbsp;All rights reserved.&nbsp;&nbsp;&nbsp;&nbsp;HAH-0001 
      </div>
    </div>
  </body>
</html>
